Our recent work identified EpCAM-positive extracellular vesicles in the ascites of patients with advanced HGSC as potential prognostic biomarkers, capable of predicting early recurrence and suggesting a likelihood of more aggressive tumor biology and chemoresistance [11]. Here, EPCAM is linked to neoplasm.